Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

PharmaEngine, Inc. (4162) Income Statement

PharmaEngine, Inc. Income Statement

Last quarter (Q2 2026), PharmaEngine, Inc.'s total revenue was NT$258.02M, an increase of 31.11% from the same quarter last year. In Q2, PharmaEngine, Inc.'s net income was NT$134.03M. See PharmaEngine, Inc.’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22Dec 21
NT$ 911.42MNT$ 2.52BNT$ 767.67MNT$ 654.38MNT$ 654.84M
NT$ 849.51MNT$ 2.48BNT$ 718.97MNT$ 604.68MNT$ 617.76M
NT$ 424.05MNT$ 422.40MNT$ 441.79MNT$ 321.94MNT$ 255.07M
Depreciation and AmortizationNT$ 10.05MNT$ 9.31MNT$ 9.02MNT$ 8.61MNT$ 10.26M
NT$ 519.48MNT$ 2.17BNT$ 347.31MNT$ 401.15MNT$ 555.87M
NT$ 425.46MNT$ 2.05BNT$ 277.18MNT$ 282.75MNT$ 362.47M
NT$ 83.83MNT$ 109.83MNT$ 60.79MNT$ 109.72MNT$ 182.92M
NT$ 509.29MNT$ 2.16BNT$ 337.97MNT$ 392.46MNT$ 545.39M
NT$ 387.64MNT$ 1.75BNT$ 274.65MNT$ 318.78MNT$ 426.03M
Per Share Metrics
Basic EPSNT$ 2.70NT$ 12.16NT$ 1.91NT$ 2.22NT$ 2.95
Diluted EPSNT$ 2.69NT$ 12.16NT$ 1.91NT$ 2.22NT$ 2.94
Weighted Average Shares Outstanding143.66M143.64M143.74M143.60M144.54M
Weighted Average Shares Outstanding (Diluted)143.94M143.93M143.74M143.70M144.74M

Currency in TWD

PharmaEngine, Inc. Earnings and Revenue History

01B2B3B0 %25 %50 %75 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin